Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Matthew Beuchel

Orthopaedic Surgery Fort Wayne, IN Medical Doctor

NPI 1306075742 CMS profile 331326

7601 W Jefferson Blvd, Fort Wayne, IN 46804

Open in the dashboard

General payments

$17,049

118 records reported · program years 2019–2025

Research payments

$6,047

Paid to them · 7 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Matthew Beuchel of Fort Wayne, IN is reported in the CMS Open Payments database as having received $17,049 across 118 general payments and $6,047 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 81st percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $11,788 26
2025 Research $735 2
2024 General $652 15
2024 Research $1,300 2
2023 General $1,597 23
2023 Research $4,012 3
2022 General $205 5
2021 General $1,059 21
2020 General $389 11
2019 General $1,359 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Matthew Beuchel
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Matthew Beuchel were reported at $11,788. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Matthew Beuchel Orthopaedic Surgery median Middle half National median
2019 $1,359 $644 $140–$2,844 $163
2020 $389 $312 $75–$1,860 $114
2021 $1,059 $520 $117–$2,495 $132
2022 $205 $598 $128–$2,731 $149
2023 $1,597 $461 $128–$2,264 $160
2024 $652 $497 $134–$2,475 $164
2025 $11,788 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Treace Medical Concepts, Inc. $11,427 22 payments
  2. Stryker Corporation $3,944 63 payments
  3. Paragon 28, Inc. $699 17 payments
  4. Wright Medical Technology, Inc. $454 1 payment
  5. Smith+Nephew, Inc. $117 6 payments
  6. Zimmer Biomet Holdings, Inc. $103 1 payment
  7. Crossroads Orthopedics, LLC $101 2 payments
  8. Exactech, Inc. $88 1 payment
  9. DePuy Synthes Sales Inc. $83 3 payments
  10. Bioventus LLC $33 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $10,238 4 payments
  2. Food and Beverage $4,199 95 payments
  3. Travel and Lodging $2,159 18 payments
  4. Gift $454 1 payment
Products named General payments · program years 2019–2025
  1. LAPIPLASTY SYSTEM 1 $10,839 7 payments
  2. PROSTEP $1,054 8 payments
  3. INBONE $507 8 payments
  4. STAR $503 5 payments
  5. INFINITY $454 1 payment
  6. TAR $449 9 payments
  7. LAPIPLASTY SYSTEM $283 9 payments
  8. PROPHECY $251 3 payments
  9. MAKO $245 7 payments
  10. VARIAX $228 5 payments
  11. Other $2,256 55 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Paragon 28, Inc. $6,047 7 payments

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

114

Median for Orthopedic Surgery: 203

Drug cost

$528

Median for Orthopedic Surgery: $1,433

Branded share of claims

21.1%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 24 $195
Methylprednisolone Generic 25 $163
Gabapentin Generic 11 $100
Meloxicam Generic 26 $40
Amoxicillin Generic 28 $29

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 85 billing codes

Paid by Medicare

$78,693

Of which drugs: $4,173

Medicare patients

321

Average age 71

Services billed

8,432

203 women, 118 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 72%
Diabetes 32%
Depression 28%
Ischemic heart disease 26%
Chronic kidney disease 21%
COPD 15%
Atrial fibrillation 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 66 7,264 $747
Injection, methylprednisolone acetate, 40 mg J1030 Office 29 60 $207

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

125 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record